antisense oligonucleotides (Leiden University Medical Center)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantisense oligonucleotides (Leiden University Medical Center)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionComplement C5 inhibitorsInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptorComplement C5
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeiden University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeiden University Medical Center
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A